Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Sell
37
WNC Quote, Financials, Valuation and Earnings
Last price:
$17.00
Seasonality move
:
14.27%
Day range:
$16.55 - $17.07
52-week range:
$15.94 - $30.07
Dividend yield:
1.9%
P/E ratio:
5.69x
P/S ratio:
0.36x
P/B ratio:
3.64x
Volume:
523.3K
Avg. volume:
516.6K
1-year change:
-34.78%
Market cap:
$729.8M
Revenue:
$2.5B
EPS (TTM):
-$5.43
Analysts' Opinion
-
Consensus RatingWabash National has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Wabash National has an estimated upside of 27.67% from its current price of $16.84.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $16.84.
Fair Value
-
According to the consensus of 0 analysts, Wabash National has 27.67% upside to fair value with a price target of -- per share.
WNC vs. S&P 500
-
Over the past 5 trading days, Wabash National has underperformed the S&P 500 by -10.77% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Wabash National does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Wabash National revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Wabash National reported revenues of $464M.
Earnings Growth
-
Wabash National earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Wabash National reported earnings per share of -$7.53.
Enterprise value:
1B
EV / Invested capital:
1.75x
Price / LTM sales:
0.36x
EV / EBIT:
5.31x
EV / Revenue:
0.49x
PEG ratio (5yr expected):
0.17x
EV / Free cash flow:
11.95x
Price / Operating cash flow:
8.78x
Enterprise value / EBITDA:
4.28x
Gross Profit (TTM):
$330.3M
Return On Assets:
-16.8%
Net Income Margin (TTM):
-10.94%
Return On Equity:
-49.14%
Return On Invested Capital:
-26.74%
Operating Margin:
-93.33%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $2.3B | $2.6B | $2.1B | $632.8M | $464M | |
| Gross Profit | $270.7M | $484.6M | $330.3M | $122.9M | $56M | |
| Operating Income | $119.2M | $308.7M | -$297.6M | $77.8M | -$433.1M | |
| EBITDA | $130.1M | $353.6M | -$244.7M | $91M | -$419.4M | |
| Diluted EPS | $0.92 | $4.58 | -$5.43 | $1.16 | -$7.53 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $566.5M | $582.2M | $674.5M | $721M | $639.5M | |
| Total Assets | $1.2B | $1.2B | $1.3B | $1.4B | $1.5B | |
| Current Liabilities | $279.8M | $288M | $397.4M | $393.2M | $339.3M | |
| Total Liabilities | $798.7M | $785.1M | $908.8M | $870.2M | $1.3B | |
| Total Equity | $397.4M | $386.2M | $360.5M | $519.2M | $201.2M | |
| Total Debt | $458.7M | $419.1M | $443.7M | $396.3M | $397M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $138.9M | $256.5M | $151.4M | $58.3M | $42.8M | |
| Cash From Investing | -$69.7M | -$103.5M | -$76.6M | -$30M | -$16.2M | |
| Cash From Financing | -$37.1M | -$129.2M | -$98.2M | -$21.8M | -$22M | |
| Free Cash Flow | $67.7M | $156.7M | $87.5M | $29M | $28.2M | |
WNC
Sector
Market Cap
$729.8M
$764.1M
Price % of 52-Week High
56%
78.36%
Dividend Yield
1.9%
0%
Shareholder Yield
11.58%
2.32%
1-Year Price Total Return
-34.78%
-1.72%
Beta (5-Year)
1.547
0.899
Dividend yield:
1.9%
Annualized payout:
$0.32
Payout ratio:
-6.45%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$17.92
200-day SMA
Sell
Level
$21.37
Bollinger Bands (100)
Sell
Level
18.1 - 19.72
Chaikin Money Flow
Buy
Level
10.4M
20-day SMA
Sell
Level
$19.03
Relative Strength Index (RSI14)
Sell
Level
30.57
ADX Line
Sell
Level
19.93
Williams %R
Buy
Level
-92.893
50-day SMA
Sell
Level
$18.71
MACD (12, 26)
Sell
Level
-0.48
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Neutral
Level
94.3M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.1862)
Buy
CA Score
(Annual)
Level (0.8159)
Buy
Beneish M-Score
(Annual)
Level (-3.2301)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.6389)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The company’s mission is to enable customers to succeed with breakthrough ideas and solutions that help them move everything from the first to the final mile. It designs and manufactures a diverse variety of products, including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.
Stock Forecast FAQ
In the current month, WNC has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The WNC average analyst price target in the past 3 months is --.
-
Where Will Wabash National Stock Be In 1 Year?
According to analysts, the consensus estimate is that Wabash National share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Wabash National?
Analysts are divided on their view about Wabash National share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Wabash National is a Sell and believe this share price will drop from its current level to --.
-
What Is Wabash National's Price Target?
The price target for Wabash National over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is WNC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Wabash National is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of WNC?
You can purchase shares of Wabash National via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Wabash National shares.
-
What Is The Wabash National Share Price Today?
Wabash National was last trading at $17.00 per share. This represents the most recent stock quote for Wabash National. Yesterday, Wabash National closed at $16.84 per share.
-
How To Buy Wabash National Stock Online?
In order to purchase Wabash National stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 8.05% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 0.76% over the past day.
Sell
48
VRNA alert for Dec 24
Verona Pharma PLC [VRNA] is down 0.4% over the past day.
